跳至主要内容
临床试验/NCT00679575
NCT00679575已完成不适用

Statins and Risk of Myocardial Infarction in Real Life in France

AstraZeneca1 个研究点 分布在 1 个国家目标入组 13,171 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
13,171
试验地点
1
主要终点
Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France

研究概览

简要总结

The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients can speak French or English
  • Patients can be interviewed by telephone
  • Place of usual residence in the area of recruitment

排除标准

  • Patients refusing to participate in the study
  • Patients who cannot be reached by telephone
  • Previous history of myocardial infarction

结局指标

主要结局

Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France

时间窗: in 2011

次要结局

  • Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities(in 2011)
  • Assess the populational impact of statins usage on the risk of having a first myocardial infarction(in 2011)
  • Assess the risk of having a first myocardial infarction according to high and low dosages of statins(in 2011)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验